Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fish Oil for Atrial Fibrillation
NCT00552084Phase 4Completed
- Sponsor
- Vanderbilt University
- Start
- Nov 2007
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in Atrial fibrillation (AFib), sponsored by Vanderbilt University. Started Nov 2007; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00552084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00552084.